School of Biological and Medical Engineering, Hefei University of Technology, Hefei, 230009, China.
Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
Mini Rev Med Chem. 2019;19(10):809-825. doi: 10.2174/1389557519666190128093840.
Resveratrol is a non-flavonoid polyphenol containing a terpenoid backbone. It has been intensively studied because of its various promising biological properties, such as anticancer, antioxidant, antibacterial, neuroprotective and anti-inflammatory activities. However, the medicinal application of resveratrol is constrained by its poor bioavailability and stability. In the past decade, more attention has been focused on making resveratrol derivatives to improve its pharmacological activities and pharmacokinetics. This review covers the literature published over the past 15 years on synthetic analogues of resveratrol. The emphasis is on the chemistry of new compounds and relevant biological activities along with structure-activity relationship. This review aims to provide a scientific and reliable basis for the development of resveratrol-based clinical drugs.
白藜芦醇是一种含有萜烯骨架的非黄酮多酚。由于其具有多种有前途的生物学特性,如抗癌、抗氧化、抗菌、神经保护和抗炎活性,因此它受到了广泛的研究。然而,白藜芦醇的药用应用受到其生物利用度和稳定性差的限制。在过去的十年中,人们越来越关注合成白藜芦醇衍生物以提高其药理活性和药代动力学。本综述涵盖了过去 15 年关于白藜芦醇合成类似物的文献。重点介绍了新化合物的化学性质及其相关的生物学活性以及构效关系。本综述旨在为基于白藜芦醇的临床药物的开发提供科学可靠的依据。